X-154531950-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_001360016.2(G6PD):c.*50G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000712 in 912,918 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., 3 hem., cov: 20)
Exomes 𝑓: 0.000044 ( 0 hom. 18 hem. )
Consequence
G6PD
NM_001360016.2 3_prime_UTR
NM_001360016.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.73
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS2
High Hemizygotes in GnomAd4 at 3 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.*50G>A | 3_prime_UTR_variant | 13/13 | ENST00000393562.10 | ||
G6PD | NM_000402.4 | c.*50G>A | 3_prime_UTR_variant | 13/13 | |||
G6PD | NM_001042351.3 | c.*50G>A | 3_prime_UTR_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.*50G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_001360016.2 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000331 AC: 29AN: 87486Hom.: 0 Cov.: 20 AF XY: 0.000135 AC XY: 3AN XY: 22162
GnomAD3 genomes
AF:
AC:
29
AN:
87486
Hom.:
Cov.:
20
AF XY:
AC XY:
3
AN XY:
22162
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000110 AC: 15AN: 135932Hom.: 0 AF XY: 0.000121 AC XY: 5AN XY: 41366
GnomAD3 exomes
AF:
AC:
15
AN:
135932
Hom.:
AF XY:
AC XY:
5
AN XY:
41366
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000436 AC: 36AN: 825403Hom.: 0 Cov.: 32 AF XY: 0.0000711 AC XY: 18AN XY: 253167
GnomAD4 exome
AF:
AC:
36
AN:
825403
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
253167
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000331 AC: 29AN: 87515Hom.: 0 Cov.: 20 AF XY: 0.000135 AC XY: 3AN XY: 22185
GnomAD4 genome
AF:
AC:
29
AN:
87515
Hom.:
Cov.:
20
AF XY:
AC XY:
3
AN XY:
22185
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 14, 2012 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at